Elegen

Menlo Park, CA · Founded 2017 · Privately Held (backing)

Developer of microfluidics technology designed to disrupt synthetic biology. Elegen is based in Menlo Park, CA and was founded in 2017. Its last known valuation is $100 million. It has raised $56.6 million across 1 recorded round; the latest was a $33 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$100.0M
Total raised
$56.6M
Last round
Early Stage VC
May 2024
How much has Elegen raised?
$56.6Macross 1 recorded rounds · May 2024 – May 2024

Most recently, Elegen raised $33.0M in its Early Stage VC (May 2024).

Free account
More of Elegen with a free account
  • ·The complete investor list: 17 names
  • ·Watch Elegen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Elegen round by round

1 rounds
May 2024Early Stage VC$33.0MSEC filing▮
28 investors participated

How much has Elegen raised?

Elegen has raised $56.6 million in total; 1 of its rounds is on record. The largest on record was a $33 million early-stage round in May 2024.

Elegen has filed 1 Form D with the SEC, most recently in May 2024 ($33 million sold to 28 investors).

Elegen investors

17 investors are on record for Elegen, including Y Combinator, Andreessen Horowitz, 8VC and National Institutes of Health. By type, the record holds 7 venture capital firms and 1 asset manager. The early-stage round in May 2024 drew 28 investors.

For fundraisers
Raising for a company like Elegen?

17 investors have backed Elegen.

See all 17 investors →

Frequently asked about Elegen

How much has Elegen raised?
Elegen has raised $56.6M in total across 1 recorded funding rounds.
When was Elegen's last funding round?
Elegen's most recent recorded round was Early Stage VC in May 2024, raising $33.0M.